Coloplast A/S (CLPBY) Short Interest Ratio & Short Volume $9.58 -0.02 (-0.22%) As of 03:58 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock Coloplast A/S Short Interest DataColoplast A/S (CLPBY) has a short interest of 171,700 shares. This marks a 43.80% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 219,387 shares to cover all short positions.Current Short Interest171,700 sharesPrevious Short Interest119,400 sharesChange Vs. Previous Month+43.80%Dollar Volume Sold Short$1.58 millionShort Interest Ratio0.3 Days to CoverLast Record DateJuly 31, 2025Today's Trading Volume137,637 sharesAverage Trading Volume219,387 sharesToday's Volume Vs. Average63% Short Selling Coloplast A/S? Sign up to receive the latest short interest report for Coloplast A/S and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLPBY Short Interest Over TimeCLPBY Days to Cover Over TimeCLPBY Percentage of Float Shorted Over Time Coloplast A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025171,700 shares $1.58 million +43.8%N/A0.3 $9.22 7/15/2025119,400 shares $1.12 million +63.1%N/A0.3 $9.35 6/30/202573,200 shares $693.94 thousand +19.6%N/A0.1 $9.48 6/15/202561,200 shares $597.31 thousand +1.3%N/A0.2 $9.76 5/31/202560,400 shares $575.61 thousand -2.9%N/A0.2 $9.53 5/15/202562,200 shares $595.88 thousand -67.9%N/A0.1 $9.58 4/30/2025193,800 shares $2.19 million -17.9%N/A0.6 $11.28 4/15/2025235,900 shares $2.49 million +121.7%N/A0.5 $10.57 3/31/2025106,400 shares $1.12 million -62.1%N/A0.3 $10.50 3/15/2025280,600 shares $2.96 million +264.4%N/A0.6 $10.54 Get the Latest News and Ratings for CLPBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter. 2/28/202577,000 shares $816.20 thousand +26.9%N/A0.3 $10.60 2/15/202560,700 shares $681.05 thousand -42.6%N/A0.3 $11.22 1/31/2025105,800 shares $1.22 million +72.3%N/A0.2 $11.51 1/15/202561,400 shares $674.17 thousand +2.0%N/A0.2 $10.98 12/31/202460,200 shares $653.77 thousand No ChangeN/A0.1 $10.86 12/15/202460,200 shares $703.14 thousand No ChangeN/A0.2 $11.68 11/30/202460,200 shares $760.93 thousand -26.6%N/A0.3 $12.64 11/15/202482,000 shares $1.05 million +2.2%N/A0.5 $12.78 10/31/202480,200 shares $1.00 million +27.7%N/A0.7 $12.52 10/15/202462,800 shares $810.12 thousand -14.3%N/A0.5 $12.90 9/30/202473,300 shares $959.31 thousand -2.1%N/A0.7 $13.09 9/15/202474,900 shares $1.05 million -0.1%N/A0.9 $13.99 8/31/202475,000 shares $1.03 million -27.5%N/A0.8 $13.67 8/15/2024103,500 shares $1.42 million -16.3%N/A0.9 $13.71 7/31/2024123,600 shares $1.61 million +55.1%N/A1.1 $13.06 7/15/202479,700 shares $1.02 million -12.1%N/A0.6 $12.80 6/30/202490,700 shares $1.10 million -59.9%N/A0.4 $12.08 6/15/2024226,200 shares $2.75 million -41.9%N/A1.2 $12.15 5/31/2024389,400 shares $4.70 million +567.9%N/A0.3 $12.06 5/15/202458,300 shares $730.50 thousand -37.0%N/A0.5 $12.53 4/30/202492,500 shares $1.13 million +504.6%N/A0.5 $12.19 4/15/202415,300 shares $198.90 thousand +93.7%N/A0.2 $13.00 3/31/20247,900 shares $106.89 thousand +203.9%N/A0.1 $13.53 3/15/20242,600 shares $35.62 thousand -99.5%N/A0 $13.70 2/29/2024546,900 shares $7.32 million +1,948.3%N/A1.1 $13.39 2/15/202426,700 shares $344.96 thousand -84.5%N/A0.1 $12.92 1/15/202425,700 shares $311.48 thousand +93.2%N/A0.4 $12.12 12/31/202313,300 shares $153.35 thousand +923.1%N/A0.1 $11.53 12/15/20231,300 shares $14.89 thousand +62.5%N/A0 $11.45 11/30/2023800 shares $9.40 thousand -79.5%N/A0 $11.75A New Way to Double Your Retirement Income? (Ad)Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.Click here to see how to turn your savings into a monthly income machine. 11/15/20233,900 shares $41.77 thousand -95.3%N/A0 $10.71 10/31/202383,500 shares $876.75 thousand +77.7%N/A0.4 $10.50 10/15/202347,000 shares $478.46 thousand +46,900.0%N/A0.3 $10.18 9/30/2023100 shares $1.06 thousand -99.8%N/A0 $10.57 9/15/202351,600 shares $572.89 thousand +493.1%N/A0.4 $11.10 8/31/20238,700 shares $99.35 thousand -85.8%N/A0.1 $11.42 8/15/202361,300 shares $736.83 thousand -17.9%N/A0.8 $12.02 7/31/202374,700 shares $929.27 thousand -12.6%N/A1.2 $12.44 7/15/202385,500 shares $1.04 million +71.0%N/A1.1 $12.15 6/30/202350,000 shares $627.50 thousand +103.3%N/A0.4 $12.55 6/15/202324,600 shares $307.25 thousand +1,540.0%N/A0.3 $12.49 5/31/20231,500 shares $18.95 thousand -34.8%N/A0 $12.64 5/15/20232,300 shares $30.87 thousand -87.1%N/A0 $13.42 4/30/202317,800 shares $256.50 thousand -34.3%N/A0.5 $14.41 4/15/202327,100 shares $375.20 thousand +118.6%N/A0.4 $13.85 3/31/202312,400 shares $162.47 thousand -12.1%N/A0.2 $13.10 3/15/202314,100 shares $163.28 thousand +3,425.0%N/A0.2 $11.58 2/28/2023400 shares $4.59 thousand -98.9%N/A0 $11.48 2/15/202335,300 shares $414.07 thousand +9.6%N/A0.5 $11.73 1/31/202332,200 shares $390.59 thousand -26.5%N/A0.3 $12.13 1/15/202343,800 shares $546.46 thousand +40.4%N/A0.4 $12.48 12/30/202231,200 shares $362.86 thousand +10,300.0%N/A0.2 $11.63 12/15/2022300 shares $3.62 thousand -99.3%N/A0 $12.08 11/30/202244,400 shares $522.14 thousand -45.8%N/A0.4 $11.76 11/15/202281,900 shares $1.01 million +9,000.0%N/A0.3 $12.30 10/31/2022900 shares $10.00 thousand -30.8%N/A0 $11.11 10/15/20221,300 shares $13.09 thousand -97.0%N/A0 $10.07 9/30/202242,600 shares $434.31 thousand -44.8%N/A0.1 $10.20 9/15/202277,100 shares $901.30 thousand -30.0%N/A0.4 $11.69 8/31/2022110,100 shares $1.26 million +83.5%N/A0.7 $11.47 8/15/202260,000 shares $695.10 thousand +118.2%N/A0.4 $11.59 7/31/202227,500 shares $322.03 thousand +20.6%N/A0.2 $11.71 7/15/202222,800 shares $257.87 thousand -84.0%N/A0.1 $11.31 6/30/2022142,300 shares $1.62 million +351.8%N/A0.6 $11.36 6/15/202231,500 shares $333.27 thousand +505.8%N/A0.1 $10.58 5/31/20225,200 shares $61.62 thousand +73.3%N/A0 $11.85 5/15/20223,000 shares $36.30 thousand -84.3%N/A0 $12.10 4/30/202219,100 shares $258.42 thousand +365.9%N/A0.1 $13.53 4/15/20224,100 shares $63.59 thousand -63.4%N/A0 $15.51 3/31/202211,200 shares $170.24 thousand -1.8%N/A0.1 $15.20 3/15/202211,400 shares $156.41 thousand +470.0%N/A0 $13.72 2/28/20222,000 shares $29.94 thousand +1,900.0%N/A0 $14.97 2/15/2022100 shares $1.42 thousand -99.2%N/A0 $14.24 1/31/202212,800 shares $186.50 thousand +36.2%N/A0 $14.57 1/15/20229,400 shares $143.44 thousand -11.3%N/A0.1 $15.26 12/31/202110,600 shares $188.03 thousand -71.9%N/A0.1 $17.74 12/15/202137,700 shares $626.57 thousand +190.0%N/A0.3 $16.62 11/30/202113,000 shares $212.88 thousand -51.5%N/A0.1 $16.38 11/15/202126,800 shares $481.06 thousand +6.4%N/A0.2 $17.95 10/29/202125,200 shares $411.77 thousand +563.2%N/A0.3 $16.34A New Way to Double Your Retirement Income? (Ad)Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.Click here to see how to turn your savings into a monthly income machine. 10/15/20213,800 shares $60.44 thousand +216.7%N/A0 $15.91 9/30/20211,200 shares $18.78 thousand -78.6%N/A0 $15.65 9/15/20215,600 shares $97.66 thousand -76.4%N/A0.2 $17.44 8/31/202123,700 shares $412.50 thousand -4.8%N/A0.4 $17.41 8/13/202124,900 shares $449.20 thousand +32.5%N/A0.5 $18.04 7/30/202118,800 shares $346.86 thousand +45.7%N/A0.4 $18.45 7/15/202112,900 shares $220.11 thousand -27.5%N/A0.3 $17.06 6/30/202117,800 shares $291.79 thousand -56.3%N/A0.3 $16.39 6/15/202140,700 shares $656.49 thousand +80.1%N/A0.1 $16.13 5/28/202122,600 shares $359.79 thousand -8.9%N/A0.3 $15.92 5/14/202124,800 shares $389.61 thousand +12.2%N/A0.3 $15.71 4/30/202122,100 shares $369.07 thousand +183.3%N/A0.3 $16.70 4/15/20217,800 shares $121.06 thousand +34.5%N/A0.1 $15.52 3/31/20215,800 shares $87.17 thousand +75.8%N/A0 $15.03 3/15/20213,300 shares $48.77 thousand -36.5%N/A0 $14.78 2/26/20215,200 shares $80.85 thousand -73.3%N/A0.1 $15.55 2/12/202119,500 shares $331.14 thousand +72.6%N/A0.1 $16.98 1/29/202111,300 shares $173.46 thousand -54.6%N/A0.1 $15.35 1/15/202140,500 shares $589.28 thousand +159.6%N/A0.4 $14.55 12/31/2020138,500 shares $2.14 million +242.0%N/A0.9 $15.45 12/15/202040,500 shares $622.28 thousand +159.6%N/A0.4 $15.37 11/30/202015,600 shares $234.31 thousand -6.6%N/A0.2 $15.02 11/15/202016,700 shares $256.35 thousand +98.8%N/A0.2 $15.35 10/30/20208,400 shares $125.08 thousand +140.0%N/A0.1 $14.89 10/15/20203,500 shares $54.37 thousand -14.6%N/A0 $15.54 9/30/20204,100 shares $64.62 thousand -28.1%N/A0.1 $15.76 9/15/20205,700 shares $92.23 thousand -94.1%N/A0 $16.18 8/31/202096,100 shares $1.64 million +3,904.2%N/A0.7 $17.02 CLPBY Short Interest - Frequently Asked Questions What is Coloplast A/S's current short interest? Short interest is the volume of Coloplast A/S shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 171,700 shares of CLPBY short. Learn More on Coloplast A/S's current short interest. Is Coloplast A/S's short interest increasing or decreasing? Coloplast A/S saw a increase in short interest in July. As of July 31st, there was short interest totaling 171,700 shares, an increase of 43.8% from the previous total of 119,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Coloplast A/S's short interest compare to its competitors? Here is how the short interest of companies in the industry of "med instruments" compare to Coloplast A/S: Micron Solutions Inc. (0.00%), Pressure BioSciences Inc. (0.00%), Thermo Fisher Scientific Inc. (0.98%), Intuitive Surgical, Inc. (1.21%), IDEXX Laboratories, Inc. (3.13%), Edwards Lifesciences Corporation (1.39%), Alcon (1.44%), IQVIA Holdings Inc. (4.03%), DexCom, Inc. (2.17%), and Mettler-Toledo International, Inc. (3.33%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Coloplast A/S stock? Short selling CLPBY is an investing strategy that aims to generate trading profit from Coloplast A/S as its price is falling. CLPBY shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Coloplast A/S? A short squeeze for Coloplast A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLPBY, which in turn drives the price of the stock up even further. How often is Coloplast A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLPBY, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies ADLI Short Squeeze FMS Short Squeeze MICR Short Squeeze PECN Short Squeeze PBIO Short Squeeze SARTF Short Squeeze XCRP Short Squeeze TMO Short Squeeze ISRG Short Squeeze IDXX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CLPBY) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access